HI
NVO

Hudock Inc’s Novo Nordisk NVO Stock Holding History

Hudock Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Buy
+10,214
New +$439K 0.06% 135
2025
Q3 		– Sell
-7,590
Closed -$524K – 203
2025
Q2 		$524K Sell
7,590
-141
-2% -$9.59K 0.08% 103
2025
Q1 		$537K Buy
7,731
+2,423
+46% +$200K 0.09% 89
2024
Q4 		$457K Buy
5,308
+2,743
+107% +$297K 0.08% 104
2024
Q3 		$305K Sell
2,565
-727
-22% -$97K 0.05% 131
2024
Q2 		$470K Buy
3,292
+64
+2% +$8.48K 0.09% 95
2024
Q1 		$414K Buy
+3,228
New +$384K 0.09% 92

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hudock Inc's NVO Position: Q2 2026 in Review

Hudock Inc opened a new position in Novo Nordisk (NVO) in Q2 2026: 10,214 shares worth $490K. The stake represents 0.06% of the portfolio and ranks #135 among its holdings. This is a return to the name: Hudock Inc previously reported a position in NVO as recently as Q2 2025.

Hudock Inc first reported a position in NVO in Q1 2024 and has held it in 7 quarters since. The position peaked at $537K in Q1 2025. 1,352 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hudock Inc held 10,214 shares of Novo Nordisk worth $490K as of Q2 2026.
  • Novo Nordisk was a new Hudock Inc position in Q2 2026.
  • Novo Nordisk made up 0.06% of Hudock Inc's portfolio in Q2 2026, its #135 holding.
  • Hudock Inc first reported a position in Novo Nordisk in Q1 2024 and has held it in 7 quarters since.
  • Hudock Inc's Novo Nordisk position peaked at $537K in Q1 2025.
  • 1,352 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hudock Inc's 13F filing for Q2 2026, filed 31 Jul 2026.